BPC-157 is one of the most extensively studied peptides in preclinical tissue repair research, with published data spanning tendon, muscle, bone, gastrointestinal, and neurological healing models
Use the tools and knowledge that thousands of successful peptide users rely on
Khakham, C
Oral treatment of vitamin B12 deficiency
Each component is studied for a different layer of the regenerative cycle: GHK-Cu for copper-mediated extracellular-matrix and collagen signaling, BPC-157 for angiogenic and growth-factor pathways, and TB-500 (acetylated Thymosin Beta-4) for actin-driven cell migration
Originally developed in the early 1990s by Professor Frank Ng and colleagues at Monash University in Australia, this peptide was engineered to isolate the lipolytic (fat-metabolizing) properties of growth hormone while eliminating its growth-promoting, diabetogenic, and IGF-1-stimulating effects